Clinical Trial Update: A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the addition of metronomic capecitabine to standard adjuvant therapy for high-risk HER2-positive breast cancer, and recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING